A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Kidney Neoplasm|Lymphoma|Neoplasm Metastasis|Ovarian Cancer
Interventions: DRUG: PSC 833
Sponsor: National Cancer Institute (NCI)